Mexiletine for the Treatment of Muscle Cramps in ALS
Sponsor: ALS Association
This PHASE4 trial investigates Muscle Cramps in Amyotrophic Lateral Sclerosis and is currently completed. ALS Association leads this study, which shows 9 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 4 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Aug 2017 — Jun 2018 [monthly]
Completed PHASE4
-
Feb 2017 — Aug 2017 [monthly]
Completed PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE4
First recorded
May 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ALS Association
- Bjorn Oskarsson, MD
- University of California, Davis
For direct contact, visit the study record on ClinicalTrials.gov .